These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 16172178

  • 1. Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.
    Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV.
    J Clin Pharmacol; 2005 Oct; 45(10):1137-44. PubMed ID: 16172178
    [Abstract] [Full Text] [Related]

  • 2. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 3. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA, Ducharme MP, Edwards DJ, Slaughter RL, Grunberger G.
    Pharmacotherapy; 1996 May; 16(5):760-8. PubMed ID: 8888072
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S, Chompootaweep S, Thaworn N.
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [Abstract] [Full Text] [Related]

  • 6. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ.
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [Abstract] [Full Text] [Related]

  • 7. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S, Maboudian M, Warren V, Yeh CM, Dieterich HA, Howard D, Dole WP.
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [Abstract] [Full Text] [Related]

  • 8. Plasma concentration of pioglitazone in patients with type 2 diabetes on hemodialysis.
    Abe M, Kikuchi F, Okada K, Matsumoto K.
    Ther Apher Dial; 2009 Jun; 13(3):238-9. PubMed ID: 19527473
    [No Abstract] [Full Text] [Related]

  • 9. Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone.
    Tornio A, Niemi M, Neuvonen PJ, Backman JT.
    Drug Metab Dispos; 2008 Jan; 36(1):73-80. PubMed ID: 17913794
    [Abstract] [Full Text] [Related]

  • 10. Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation.
    Karim A, Zhao Z, Slater M, Bradford D, Schuster J, Laurent A.
    J Clin Pharmacol; 2007 Jul; 47(7):806-16. PubMed ID: 17463215
    [Abstract] [Full Text] [Related]

  • 11. Oral antidiabetic drugs: effect of food on absorption of pioglitazone and metformin from a fixed-dose combination tablet.
    Karim A, Slater M, Bradford D, Schwartz L, Laurent A.
    J Clin Pharmacol; 2007 Jan; 47(1):48-55. PubMed ID: 17192501
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [Abstract] [Full Text] [Related]

  • 13. Coadministration of pioglitazone or glyburide and alogliptin: pharmacokinetic drug interaction assessment in healthy participants.
    Karim A, Laurent A, Munsaka M, Wann E, Fleck P, Mekki Q.
    J Clin Pharmacol; 2009 Oct; 49(10):1210-9. PubMed ID: 19622714
    [Abstract] [Full Text] [Related]

  • 14. No pharmacokinetic interaction between ipragliflozin and sitagliptin, pioglitazone, or glimepiride in healthy subjects.
    Smulders RA, Zhang W, Veltkamp SA, van Dijk J, Krauwinkel WJ, Keirns J, Kadokura T.
    Diabetes Obes Metab; 2012 Oct; 14(10):937-43. PubMed ID: 22587345
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
    Manitpisitkul P, Curtin CR, Shalayda K, Wang SS, Ford L, Heald D.
    Epilepsy Res; 2014 Nov; 108(9):1519-32. PubMed ID: 25219351
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
    Wearn JM, Crisman MV, Davis JL, Geor RJ, Hodgson DR, Suagee JK, Ashraf-Khorassani M, McCutcheon LJ.
    J Vet Pharmacol Ther; 2011 Jun; 34(3):252-8. PubMed ID: 21492190
    [Abstract] [Full Text] [Related]

  • 17. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S.
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of pioglitazone in lean and obese cats.
    Clark MH, Hoenig M, Ferguson DC, Dirikolu L.
    J Vet Pharmacol Ther; 2012 Oct; 35(5):428-36. PubMed ID: 22612529
    [Abstract] [Full Text] [Related]

  • 19. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
    Choi JS, Koh YY, Chung JH, Choi DH, Han HK.
    J Pharm Pharmacol; 2008 Oct; 60(10):1403-7. PubMed ID: 18812034
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW, Pennick M, Fiske K, Lyne A, Shojaei A.
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.